Leerink Partners Starts Evolent Health (EVH) at Outperform

Leerink Partners initiates coverage on Evolent Health (NYSE: EVH) with a Outperform rating.

Analyst David Larsen commented, "We are initiating coverage of Evolent Health (EVH) with an Outperform rating. We believe EVH is one of the few HCIT vendors that has its full focus on population health management (PHM), which is EMR agnostic with full health plan capabilities available to its clients through various partnerships. We also believe EVH is a well-established leader in a rapidly growing market, with a proven management team. Health plans are pushing more risk and value-based care metrics onto providers, and EVH can work with Integrated Delivery Networks (IDNs) to enable them to perform well under a multitude of complex managed care arrangements. While EVH trades at a premium to ATHN (OP) and CERN (OP), we believe the firm's superior top-line growth rate and rapidly growing market justify a higher multiple. We initiate on EVH with an OP rating, based on a growing market and quality solution."

For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.

Shares of Evolent Health closed at $18.85 yesterday.

You May Also Be Interested In

• UBS Starts Elevra Lithium (ELV:AU) at Buy
• Bernstein SocGen Group Starts Wuxi Biologics (2269:HK) (WXXWY) at Market Perform
• Bernstein SocGen Group Starts WuXi AppTec Co Ltd (603259:CH) at Outperform